Doi, T., Yoh, K., Shitara, K., Takahashi, H., Ueno, M., Kobayashi, S., . . . Furuse, J. (2018). First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors. Invest New Drugs.
Chicago Stili AlıntıDoi, Toshihiko, et al. "First-in-human Phase 1 Study of Novel DUTPase Inhibitor TAS-114 in Combination With S-1 in Japanese Patients With Advanced Solid Tumors." Invest New Drugs 2018.
MLA AlıntıDoi, Toshihiko, et al. "First-in-human Phase 1 Study of Novel DUTPase Inhibitor TAS-114 in Combination With S-1 in Japanese Patients With Advanced Solid Tumors." Invest New Drugs 2018.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..